Fiore Cannabis Ltd.
FIORF · OTC
12/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.01 | 0.05 | -0.13 |
| FCF Yield | -42.00% | -36.11% | -57.20% | -29.96% |
| EV / EBITDA | -4.67 | 3.06 | -2.70 | -3.46 |
| Quality | ||||
| ROIC | -43.92% | -46.91% | -51.78% | -75.44% |
| Gross Margin | 22.57% | 24.21% | 39.18% | 0.00% |
| Cash Conversion Ratio | 0.42 | 0.07 | 0.44 | 0.27 |
| Growth | ||||
| Revenue 3-Year CAGR | 29.22% | – | 56.09% | – |
| Free Cash Flow Growth | 0.00% | 84.43% | -28.65% | -112.26% |
| Safety | ||||
| Net Debt / EBITDA | -2.71 | 1.03 | -0.35 | -0.01 |
| Interest Coverage | -4.47 | -5.09 | -22.45 | -55.62 |
| Efficiency | ||||
| Inventory Turnover | 1.39 | 2.39 | 1.33 | 0.00 |
| Cash Conversion Cycle | -157.58 | -952.60 | -373.49 | 0.00 |